The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Eye-Opening Experiences: Tips from a Rheumatology-Ophthalmology Clinic

Eye-Opening Experiences: Tips from a Rheumatology-Ophthalmology Clinic

November 23, 2021 • By Samantha C. Shapiro, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Prostock-studio / shutterstock.com

Prostock-studio / shutterstock.com

ACR CONVERGENCE 2021—Rheumatic conditions can affect the eye in myriad ways, but ocular inflammation can be challenging for the rheumatologist to understand and manage. Jason Kolfenbach, MD, associate professor of medicine and ophthalmology, and program director of the Rheumatology Fellowship Program, University of Colorado School of Medicine, Aurora, and Alan G. Palestine, MD, professor of ophthalmology and medicine, and chief of the Uveitis and Ocular Immunology Section, University of Colorado School of Medicine, provided a unique overview of inflammatory eye disease and the overlap with systemic rheumatic illnesses at an ACR Convergence 2021 session.

You Might Also Like
  • 2013 ACR/ARHP Annual Meeting: Inflammatory Eye Disease Management Can Benefit from Collaboration between Rheumatologists and Ophthalmologists
  • Researcher Looks at Link between Arthritis and Eye Disease
  • Optical Workings: Specialists Must Communicate to Treat Eye Disease
Explore This Issue
February 2022
Also By This Author
  • Clinical Challenges in SLE: Glucocorticoids—How Much Is Too Much?

Rheumatology & the Eye

Dr. Kolfenbach

Dr. Kolfenbach discussed the intersection between rheumatology and ophthalmology with an intriguing case-based presentation. “The eye is a common target of many rheumatic illnesses,” he said. “Most inflammatory eye disease is idiopathic, but studies estimate 25 to 40% of uveitis and more than 50% of nodular or necrotizing scleritis are associated with an underlying systemic illness.”1,2

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

First, Dr. Kolfenbach shared the case of a young woman with Cogan syndrome, which is characterized by acute-onset ocular and audiovestibular signs within one to six months of each other. Interstitial keratitis, bilateral sensorineural hearing loss and vestibular dysfunction are classic presentations, although other manifestations may occur. These patients may also experience constitutional symptoms, joint pain, lymphadenopathy and a medium- to large-vessel vasculitis, which occurs in 15–20% of cases. Treatment depends on the manifestation present, with ocular disease responding well to topical steroids, hearing loss to oral immunosuppressants like methotrexate or azathioprine, and vasculitis typically requiring cyclophosphamide.3

Next, he turned to the case of a 69-year-old gentleman with untreated ankylosing spondylitis and unilateral anterior uveitis. His exam was notable for ciliary flush in the limbus region of the eye and synechiae. “White blood cells and protein in the anterior chamber cause stickiness between the iris and lens, resulting in synechiae—which is essentially an adhesion between these two structures in the eye,” Dr. Kolfenbach explained. He offered the following pearl: “If unilateral uveitis is recurrent, spondyloarthritis (SpA) comprises nearly half of cases, so we need to identify and intervene earlier to ensure better SpA outcomes over time.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Uveitis may often feel like the tip of the iceberg, with a laundry list of infectious malignant and inflammatory conditions as potential etiologies. So where does one start? Dr. Kolfenbach recommended approaching the differential based on the anatomic segment of the eye involved. For recurrent uveitis cases, he recommends:

Pages: 1 2 3 | Single Page

Filed Under: ACR Convergence, Conditions, Meeting Reports Tagged With: ACR Convergence 2021, eyes, ophthalmology, UveitisIssue: February 2022

You Might Also Like:
  • 2013 ACR/ARHP Annual Meeting: Inflammatory Eye Disease Management Can Benefit from Collaboration between Rheumatologists and Ophthalmologists
  • Researcher Looks at Link between Arthritis and Eye Disease
  • Optical Workings: Specialists Must Communicate to Treat Eye Disease
  • Gut Microbes Activate T Cells Causing Autoimmune Eye Disease

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)